Do you need Lp(a) testing? New heart-risk guidance changes the conversation

The American Heart Association’s new dyslipidemia guidance puts lipoprotein(a), or Lp(a), on more clinicians’ radar. For many adults, the test is meant to refine heart-risk assessment — not replace a standard cholesterol panel or by itself tell you whether you need treatment. That matters because Lp(a) is usually inherited, often does not cause symptoms, and is not checked on routine cholesterol tests. The new guidance says a one-time measurement may help identify people whose risk is higher than their usual LDL cholesterol result suggests.

The American Heart Association’s new dyslipidemia guidance puts lipoprotein(a), or Lp(a), on more clinicians’ radar. For many adults, the test is meant to refine heart-risk assessment — not replace a standard cholesterol panel or by itself tell you whether you need treatment.

That matters because Lp(a) is usually inherited, often does not cause symptoms, and is not checked on routine cholesterol tests. The new guidance says a one-time measurement may help identify people whose risk is higher than their usual LDL cholesterol result suggests.

What changed

In March 2026, the American Heart Association said its updated dyslipidemia guideline now recommends Lp(a) testing at least once in a lifetime, along with selective apolipoprotein B testing and broader use of coronary artery calcium scoring in some cases. The guideline replaces the 2018 AHA/ACC cholesterol guidance and reflects a wider view of cardiovascular risk beyond LDL cholesterol alone.

What Lp(a) is

Lp(a) is a blood lipoprotein that carries cholesterol and is largely determined by genes. Unlike LDL cholesterol, which can rise or fall with diet, exercise, and medicine, Lp(a) is usually more stable across life. CDC notes that inherited cholesterol conditions can run in families and raise the chance of coronary artery disease and heart attack.

How the test fits with routine cholesterol screening

A regular lipid panel does not measure Lp(a). CDC says most healthy adults should have their cholesterol checked every 4 to 6 years, and people who have heart disease, diabetes, or a family history of high cholesterol may need checks more often. Lp(a) is being added as a one-time risk marker, not as a replacement for LDL cholesterol, blood pressure, diabetes screening, smoking assessment, or other standard prevention tools.

Who may benefit most

The new guidance is most relevant for people whose risk is harder to judge from standard numbers alone, including those with a family history of early heart disease, inherited cholesterol problems, or other risk-enhancer situations. It may also help when a clinician is deciding how aggressively to manage cholesterol-related risk.

What a result can and cannot tell you

A higher Lp(a) result can help explain why someone’s heart risk is greater than expected. But it is not a diagnosis of heart disease, and it is not a stand-alone reason to start, stop, or change treatment on its own. It is one part of a bigger risk picture that still includes LDL cholesterol, blood pressure, diabetes, smoking, age, sex, and in some cases coronary artery calcium scoring.

That is especially important because the main practical value of Lp(a) right now is risk refinement. It can help a clinician and patient decide how closely to follow other risk factors and whether more prevention steps make sense.

Practical questions to ask at the doctor’s office

  • Have I already had an Lp(a) test, and if so, what was the result?
  • Does my family history or cholesterol pattern make Lp(a) testing useful?
  • If my Lp(a) is high, how does that change my overall heart-risk plan?
  • Will my insurance cover the test, or should I ask about out-of-pocket costs first?

Coverage can vary. CMS policy language distinguishes between diagnostic testing and screening, and Medicare has long limited routine screening coverage unless it is specifically authorized. In practice, whether a test or follow-up service is covered depends on the reason for the order, the plan, and the setting.

The bottom line

Lp(a) testing is becoming more important because it can uncover inherited heart risk that a standard cholesterol panel may miss. For many people, it is best understood as a risk-assessment tool — useful when interpreted with the rest of your heart-health picture, but not a stand-alone answer.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.